08/26/2026 | Press release | Distributed by Public on 08/26/2026 12:42
| Fund | Costs of a $10,000 investment | Costs paid as a percentage of a $10,000 investment |
| BNY Mellon Large Cap Securities Fund, Inc. | $35 | 0.68%* |
| * |
Annualized.
|
|
Fund Size (Millions) |
Number of Holdings |
Portfolio Turnover |
| $2,408 | 51 | 16.34% |
| Item 2. | Code of Ethics. |
Not applicable.
| Item 3. | Audit Committee Financial Expert. |
Not applicable.
| Item 4. | Principal Accountant Fees and Services. |
Not applicable.
| Item 5. | Audit Committee of Listed Registrants. |
Not applicable.
| Item 6. | Investments. |
Not applicable.
|
Class
|
Ticker
|
|
Single Share
|
DREVX
|
|
Item 7. Financial Statements and Financial Highlights for Open-End Management
Investment Companies
|
3
|
|
Schedule of Investments
|
3
|
|
Statement of Assets and Liabilities
|
6
|
|
Statement of Operations
|
7
|
|
Statement of Changes in Net Assets
|
8
|
|
Financial Highlights
|
9
|
|
Notes to Financial Statements
|
10
|
|
Item 8. Changes in and Disagreements with Accountants for Open-End Management
Investment Companies
|
15
|
|
Item 9. Proxy Disclosures for Open-End Management Investment Companies
|
16
|
|
Item 10. Remuneration Paid to Directors, Officers, and Other of Open-End
Management Investment Companies
|
17
|
|
Item 11. Statement Regarding Basis for Approval of Investment Advisory Contracts
|
18
|
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Equity Securities - Common Stocks - 99.8%
|
|||||
|
Banks - 7.1%
|
|||||
|
Bank of America Corp.
|
778,570
|
44,362,918
|
|||
|
Fifth Third Bancorp
|
571,186
|
32,197,755
|
|||
|
First Horizon Corp.
|
1,161,045
|
29,769,194
|
|||
|
JPMorgan Chase & Co.
|
194,963
|
63,817,239
|
|||
|
|
170,147,106
|
||||
|
Capital Goods - 13.5%
|
|||||
|
AMETEK, Inc.
|
178,184
|
43,109,837
|
|||
|
Axon Enterprise, Inc.(a)
|
45,087
|
25,276,223
|
|||
|
Carrier Global Corp.
|
338,857
|
24,855,161
|
|||
|
Dover Corp.
|
100,704
|
22,585,893
|
|||
|
GE Vernova, Inc.
|
53,402
|
62,739,874
|
|||
|
Howmet Aerospace, Inc.
|
174,187
|
46,831,917
|
|||
|
Hubbell, Inc.
|
58,446
|
30,578,947
|
|||
|
Ingersoll Rand, Inc.
|
468,544
|
38,415,923
|
|||
|
Trane Technologies PLC
|
63,428
|
31,153,296
|
|||
|
|
325,547,071
|
||||
|
Consumer Discretionary Distribution & Retail - 6.6%
|
|||||
|
Amazon.com, Inc.(a)
|
524,692
|
125,055,091
|
|||
|
The TJX Companies, Inc.
|
229,264
|
34,733,496
|
|||
|
|
159,788,587
|
||||
|
Consumer Durables & Apparel - 1.0%
|
|||||
|
Ralph Lauren Corp.
|
58,165
|
23,348,013
|
|||
|
Consumer Staples Distribution & Retail - 2.2%
|
|||||
|
Walmart, Inc.
|
459,523
|
52,045,575
|
|||
|
Energy - 2.5%
|
|||||
|
Diamondback Energy, Inc.
|
69,720
|
12,255,382
|
|||
|
EQT Corp.
|
242,615
|
12,899,840
|
|||
|
Phillips 66
|
93,846
|
15,864,666
|
|||
|
SLB Ltd.
|
423,337
|
19,680,937
|
|||
|
|
60,700,825
|
||||
|
Financial Services - 4.9%
|
|||||
|
CME Group, Inc.
|
89,905
|
19,853,721
|
|||
|
Mastercard, Inc., Cl. A
|
77,191
|
39,645,298
|
|||
|
The Goldman Sachs Group, Inc.
|
57,577
|
58,231,650
|
|||
|
|
117,730,669
|
||||
|
Health Care Equipment & Services - 4.1%
|
|||||
|
Edwards Lifesciences Corp.(a)
|
235,612
|
21,313,462
|
|||
|
IDEXX Laboratories, Inc.(a)
|
47,648
|
25,083,813
|
|||
|
UnitedHealth Group, Inc.
|
123,167
|
51,191,900
|
|||
|
|
97,589,175
|
||||
|
Household & Personal Products - .9%
|
|||||
|
The Estee Lauder Companies, Inc., Cl. A
|
265,470
|
20,958,856
|
|||
|
Insurance - 2.5%
|
|||||
|
Aon PLC, Cl. A
|
78,230
|
25,948,109
|
|||
|
Assurant, Inc.
|
130,061
|
34,925,280
|
|||
|
|
60,873,389
|
||||
|
Materials - .9%
|
|||||
|
International Paper Co.
|
598,316
|
22,795,840
|
|||
|
Description
|
|
|
|
Shares
|
Value ($)
|
|
Equity Securities - Common Stocks - 99.8% (continued)
|
|||||
|
Media & Entertainment - 9.5%
|
|||||
|
Alphabet, Inc., Cl. C
|
452,463
|
159,868,752
|
|||
|
Meta Platforms, Inc., Cl. A
|
120,618
|
67,942,913
|
|||
|
|
227,811,665
|
||||
|
Pharmaceuticals, Biotechnology & Life Sciences - 5.6%
|
|||||
|
Gilead Sciences, Inc.
|
252,456
|
31,895,291
|
|||
|
Insmed, Inc.(a)
|
172,071
|
18,346,210
|
|||
|
Johnson & Johnson
|
225,818
|
57,350,998
|
|||
|
Thermo Fisher Scientific, Inc.
|
56,845
|
28,499,809
|
|||
|
|
136,092,308
|
||||
|
Semiconductors & Semiconductor Equipment - 19.8%
|
|||||
|
Marvell Technology, Inc.
|
136,647
|
40,705,775
|
|||
|
Micron Technology, Inc.
|
70,311
|
81,159,284
|
|||
|
NVIDIA Corp.
|
1,239,838
|
248,079,185
|
|||
|
Taiwan Semiconductor Manufacturing Co. Ltd., ADR
|
95,659
|
45,683,869
|
|||
|
Texas Instruments, Inc.
|
207,744
|
61,922,254
|
|||
|
|
477,550,367
|
||||
|
Software & Services - 9.0%
|
|||||
|
CrowdStrike Holdings, Inc., Cl. A(a)
|
51,551
|
39,340,630
|
|||
|
Microsoft Corp.
|
346,714
|
129,331,256
|
|||
|
Shopify, Inc., Cl. A(a)
|
174,741
|
19,951,928
|
|||
|
Synopsys, Inc.(a)
|
65,145
|
29,059,230
|
|||
|
|
217,683,044
|
||||
|
Technology Hardware & Equipment - 7.7%
|
|||||
|
Apple, Inc.
|
489,909
|
141,760,068
|
|||
|
Western Digital Corp.
|
66,602
|
42,540,030
|
|||
|
|
184,300,098
|
||||
|
Utilities - 2.0%
|
|||||
|
Constellation Energy Corp.
|
104,230
|
25,887,605
|
|||
|
Dominion Energy, Inc.(b)
|
321,008
|
21,921,636
|
|||
|
|
47,809,241
|
||||
|
Total Equity Securities - Common Stocks
(cost $1,111,299,861)
|
2,402,771,829
|
||||
|
|
|
1-Day
Yield (%)
|
|
|
|
|
Investment Companies - .3%
|
|||||
|
Registered Investment Companies - .3%
|
|||||
|
BNY Dreyfus Institutional Preferred Government Plus Money Market Fund, Institutional
Shares(c)
(cost $7,321,164)
|
3.70
|
7,321,164
|
7,321,164
|
||
|
Total Investments (cost $1,118,621,025)
|
|
100.1%
|
2,410,092,993
|
||
|
Liabilities, Less Cash and Receivables
|
|
(.1%)
|
(2,245,021)
|
||
|
Net Assets
|
100.0%
|
2,407,847,972
|
|||
|
ADR-American Depositary Receipt
|
|
(a)
|
Non-income producing security.
|
|
(b)
|
Security, or portion thereof, on loan. At June 30, 2026, the value of the fund's securities on loan was $21,702,357 and the value of the collateral was
$22,425,308, consisting of U.S. Government & Agency securities. In addition, the value of collateral may include pending sales that are also on loan.
|
|
(c)
|
Investment in affiliated issuer. The investment objective of this investment company is publicly available and can be found within the investment company's
prospectus.
|
|
Affiliated Issuers
|
|||||
|
Description
|
Value ($)
12/31/2025
|
Purchases ($)†
|
Sales ($)
|
Value ($)
6/30/2026
|
Dividends/
Distributions ($)
|
|
Registered Investment Companies - .3%
|
|||||
|
BNY Dreyfus Institutional Preferred Government Plus Money
Market Fund, Institutional Shares - .3%
|
7,432,298
|
102,002,261
|
(102,113,395)
|
7,321,164
|
186,987
|
|
Investment of Cash Collateral for Securities Loaned - .0%
|
|||||
|
BNY Dreyfus Institutional Preferred Government Plus Money
Market Fund, Institutional Shares - .0%
|
-
|
91,127,956
|
(91,127,956)
|
-
|
16,351††
|
|
Total - .3%
|
7,432,298
|
193,130,217
|
(193,241,351)
|
7,321,164
|
203,338
|
|
†
|
Includes reinvested dividends/distributions.
|
|
††
|
Represents securities lending income earned from the reinvestment of cash collateral from loaned securities, net of fees and collateral investment expenses, and
other payments to and from borrowers of securities.
|
|
|
Cost
|
Value
|
|
Assets ($):
|
||
|
Investments in securities-See Schedule of Investments
(including securities on loan, valued at $21,702,357)-Note 1(c):
|
||
|
Unaffiliated issuers
|
1,111,299,861
|
2,402,771,829
|
|
Affiliated issuers
|
7,321,164
|
7,321,164
|
|
Dividends and securities lending income receivable
|
749,432
|
|
|
Receivable for shares of Common Stock subscribed
|
52,519
|
|
|
Tax reclaim receivable-Note 1(b)
|
4,418
|
|
|
Prepaid expenses
|
31,828
|
|
|
|
2,410,931,190
|
|
|
Liabilities ($):
|
||
|
Due to BNY Mellon Investment Adviser, Inc. and affiliates-Note 3(b)
|
1,326,858
|
|
|
Cash overdraft due to Custodian denominated in foreign currency
|
141,450
|
141,450
|
|
Payable for shares of Common Stock redeemed
|
1,516,610
|
|
|
Directors' fees and expenses payable
|
7,596
|
|
|
Other accrued expenses
|
90,704
|
|
|
|
3,083,218
|
|
|
Net Assets ($)
|
2,407,847,972
|
|
|
Composition of Net Assets ($):
|
||
|
Paid-in capital
|
1,052,268,444
|
|
|
Total distributable earnings (loss)
|
1,355,579,528
|
|
|
Net Assets ($)
|
2,407,847,972
|
|
|
Shares Outstanding
|
||
|
(500 million shares of $1 par value Common Stock authorized)
|
117,072,828
|
|
|
Net Asset Value Per Share ($)
|
20.57
|
|
|
|
|
Investment Income ($):
|
|
|
Income:
|
|
|
Cash dividends (net of $34,836 foreign taxes withheld at source):
|
|
|
Unaffiliated issuers
|
11,116,055
|
|
Affiliated issuers
|
186,987
|
|
Affiliated income net of rebates from securities lending-Note 1(c)
|
16,351
|
|
Interest
|
8
|
|
Total Income
|
11,319,401
|
|
Expenses:
|
|
|
Management fee-Note 3(a)
|
7,376,533
|
|
Shareholder servicing costs-Note 3(b)
|
254,118
|
|
Professional fees
|
55,637
|
|
Directors' fees and expenses-Note 3(c)
|
45,383
|
|
Loan commitment fees-Note 2
|
28,265
|
|
Registration fees
|
22,880
|
|
Chief Compliance Officer fees-Note 3(b)
|
20,353
|
|
Prospectus and shareholders' reports
|
18,602
|
|
Custodian fees-Note 3(b)
|
12,668
|
|
Shareholder and regulatory reports service fees-Note 3(b)
|
8,500
|
|
Miscellaneous
|
15,322
|
|
Total Expenses
|
7,858,261
|
|
Net Investment Income
|
3,461,140
|
|
Realized and Unrealized Gain (Loss) on Investments-Note 4 ($):
|
|
|
Net realized gain (loss) on investments and foreign currency transactions
|
64,770,284
|
|
Net change in unrealized appreciation (depreciation) on investments and foreign currency transactions
|
78,041,846
|
|
Net Realized and Unrealized Gain (Loss) on Investments
|
142,812,130
|
|
Net Increase in Net Assets Resulting from Operations
|
146,273,270
|
|
|
Six Months Ended
June 30, 2026
(Unaudited)
|
Year Ended
December 31, 2025
|
|
|
||
|
Operations ($):
|
||
|
Net investment income
|
3,461,140
|
3,945,576
|
|
Net realized gain (loss) on investments
|
64,770,284
|
246,071,570
|
|
Net change in unrealized appreciation (depreciation) on investments
|
78,041,846
|
87,478,311
|
|
Net Increase (Decrease) in Net Assets Resulting from Operations
|
146,273,270
|
337,495,457
|
|
Distributions ($):
|
||
|
Distributions to shareholders
|
(20,996,430)
|
(285,896,790)
|
|
Capital Stock Transactions ($):
|
||
|
Net proceeds from shares sold
|
18,196,577
|
70,501,674
|
|
Distributions reinvested
|
19,261,404
|
261,951,358
|
|
Cost of shares redeemed
|
(117,838,374)
|
(443,420,818)
|
|
Increase (Decrease) in Net Assets from Capital Stock Transactions
|
(80,380,393)
|
(110,967,786)
|
|
Total Increase (Decrease) in Net Assets
|
44,896,447
|
(59,369,119)
|
|
Net Assets ($):
|
||
|
Beginning of Period
|
2,362,951,525
|
2,422,320,644
|
|
End of Period
|
2,407,847,972
|
2,362,951,525
|
|
Capital Share Transactions (Shares):
|
||
|
Shares sold
|
938,971
|
3,681,946
|
|
Shares issued for distributions reinvested
|
1,058,683
|
14,085,181
|
|
Shares redeemed
|
(6,010,845)
|
(23,925,130)
|
|
Net Increase (Decrease) in Shares Outstanding
|
(4,013,191)
|
(6,158,003)
|
|
|
Six Months Ended
June 30, 2026
(Unaudited)
|
Year Ended December 31,
|
||||
|
|
2025
|
2024
|
2023
|
2022
|
2021
|
|
|
Per Share Data ($):
|
|
|
|
|
|
|
|
Net asset value, beginning of period
|
19.51
|
19.04
|
16.30
|
13.09
|
16.69
|
14.74
|
|
Investment Operations:
|
||||||
|
Net investment income(a)
|
.03
|
.03
|
.05
|
.06
|
.06
|
.06
|
|
Net realized and unrealized gain (loss) on
investments
|
1.21
|
2.95
|
4.39
|
3.98
|
(3.03
)
|
3.79
|
|
Total from Investment Operations
|
1.24
|
2.98
|
4.44
|
4.04
|
(2.97
)
|
3.85
|
|
Distributions:
|
||||||
|
Dividends from net investment income
|
(.03
)
|
(.03
)
|
(.05
)
|
(.06
)
|
(.06
)
|
(.05
)
|
|
Dividends from net realized gain on
investments
|
(.15
)
|
(2.48
)
|
(1.65
)
|
(.77
)
|
(.57
)
|
(1.85
)
|
|
Total Distributions
|
(.18
)
|
(2.51
)
|
(1.70
)
|
(.83
)
|
(.63
)
|
(1.90
)
|
|
Net asset value, end of period
|
20.57
|
19.51
|
19.04
|
16.30
|
13.09
|
16.69
|
|
Total Return (%)
|
6.46
(b)
|
16.69
|
27.34
|
31.06
|
(17.90
)
|
27.28
|
|
Ratios/Supplemental Data (%):
|
|
|
|
|
|
|
|
Ratio of total expenses to average net assets
|
.68
(c)
|
.69
|
.69
|
.71
|
.71
|
.70
|
|
Ratio of net expenses to average net assets
|
.68
(c)
|
.69
(d)
|
.68
(d)
|
.69
(d)
|
.71
(d)
|
.70
|
|
Ratio of net investment income to average
net assets
|
.30
(c)
|
.17
(d)
|
.24
(d)
|
.40
(d)
|
.41
(d)
|
.35
|
|
Portfolio Turnover Rate
|
16.34
(b)
|
26.04
|
27.75
|
29.08
|
18.20
|
17.70
|
|
Net Assets, end of period ($ x 1,000)
|
2,407,848
|
2,362,952
|
2,422,321
|
2,003,768
|
1,458,884
|
1,835,957
|
|
(a)
|
Based on average shares outstanding.
|
|
(b)
|
Not annualized.
|
|
(c)
|
Annualized.
|
|
(d)
|
Amount inclusive of reduction in fees due to earnings credits.
|
|
|
Level 1 -
Unadjusted
Quoted Prices
|
Level 2- Other
Significant
Observable Inputs
|
Level 3-
Significant
Unobservable
Inputs
|
Total
|
|
Assets ($)
|
||||
|
Investments in Securities:†
|
||||
|
Equity Securities - Common Stocks
|
2,402,771,829
|
-
|
-
|
2,402,771,829
|
|
Investment Companies
|
7,321,164
|
-
|
-
|
7,321,164
|
|
|
2,410,092,993
|
-
|
-
|
2,410,092,993
|
|
†
|
See Schedule of Investments for additional detailed categorizations, if any.
|
|
Assets ($)
|
|
|
Gross amount of securities loaned, at
value, as disclosed in the Statement
of Assets and Liabilities
|
21,702,357
|
|
Collateral (received)/posted not offset
in the Statement of
Assets and Liabilities
|
(21,702,357
)†
|
|
Net amount
|
-
|
|
†
|
The value of the related collateral received by the fund exceeded the value of the securities loaned by the fund pursuant to the securities lending agreement. In addition,
the value of collateral may include pending sales that are also on loan. See Schedule of Investments for detailed information regarding collateral received for open
securities lending.
|
| Item 12. | Disclosure of Proxy Voting Policies and Procedures for Closed-End Management Investment Companies. |
Not applicable.
| Item 13. | Portfolio Managers for Closed-End Management Investment Companies. |
Not applicable.
| Item 14. | Purchases of Equity Securities By Closed-End Management Investment Companies and Affiliated Purchasers. |
Not applicable.
| Item 15. | Submission of Matters to a Vote of Security Holders. |
There have been no materials changes to the procedures applicable to Item 15.
| Item 16. | Controls and Procedures. |
| (a) | The Registrant's principal executive and principal financial officers have concluded, based on their evaluation of the Registrant's disclosure controls and procedures as of a date within 90 days of the filing date of this report, that the Registrant's disclosure controls and procedures are reasonably designed to ensure that information required to be disclosed by the Registrant on Form N-CSR is recorded, processed, summarized and reported within the required time periods and that information required to be disclosed by the Registrant in the reports that it files or submits on Form N-CSR is accumulated and communicated to the Registrant's management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. |
| (b) | There were no changes to the Registrant's internal control over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, the Registrant's internal control over financial reporting. |
| Item 17. | Disclosure of Securities Lending Activities for Closed-End Management Investment Companies. |
Not applicable.
| Item 18. | Recovery of Erroneously Awarded Compensation. |
Not applicable.
| Item 19. | Exhibits. |
|
(a)(1) Not applicable. (a)(2) Not applicable. |
|
(a)(3) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. (a)(4) Not applicable. (a)(5) Not applicable. (b) Certification of principal executive and principal financial officers as required by Rule 30a-2(b) under the Investment Company Act of 1940. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.
BNY Mellon Large Cap Securities Fund, Inc.
By: /s/ David J. DiPetrillo
David J. DiPetrillo
President (Principal Executive Officer)
Date: August 18, 2026
Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this Report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
By: /s/ David J. DiPetrillo
David J. DiPetrillo
President (Principal Executive Officer)
Date: August 18, 2026
By: /s/ James Windels
James Windels
Treasurer (Principal Financial Officer)
Date: August 18, 2026
EXHIBIT INDEX
(a)(3) Certifications of principal executive and principal financial officers as required by Rule 30a-2(a) under the Investment Company Act of 1940. (EX-99.CERT)
(b) Certification of principal executive and principal financial officers as required by Rule 30a-2(b) under the Investment Company Act of 1940. (EX-99.906CERT)